TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
KMDA

Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.60$ -1.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow KMDA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13.8% -19.9% 2.4% 3.8% 9.2% 22.4% 14.3% -8.8% 22.1% 3.0% 29.6% 15.3%
3.9% 4.6% 4.5% 3.4% 3.2% 3.7% 3.7% 5.6% 9.4% 8.9% 8.6% 8.9%
5.2% 2.7% 1.4% 0.5% 0.8% 0.9% 0.7% 0.5% 0.9% 0.9% 0.5% 0.5%
6.7% 3.5% 1.6% 1.4% -1.2% 2.0% 3.1% 2.1% 5.5% – – –
-6.8% -12.0% 5.1% -7.7% -12.3% -1.4% -5.3% -14.5% 9.0% -12.8% 7.1% -10.6%
4.3% 3.9% 3.4% 4.3% 2.5% 1.9% 4.1% 3.7% 2.9% 4.1% 6.7% 5.9%
-37.3% 16.0% 2.1% -15.5% -4.5% -0.5% -9.9% -61.2% -2.9% -4.1% -6.7% -5.9%
– – – – – – – – – 0.0% 0.0% 6.9%
0.1% 1.8% 20.1% 15.1% 0.0% 0.0% – – – – – –
-10.7% -10.9% 1.9% -0.2% -0.5% -1.2% -1.2% 17.9% -2.9% -12.8% -0.8% -0.5%
-10.6% -9.1% 1.9% 14.9% -0.5% -1.2% 17.5% 18.6% -7.2% 15.9% -8.6% -11.0%
-62.0% -13.5% 6.4% 2.6% 4.7% 19.3% 20.7% -49.8% 12.1% 15.0% 14.2% -1.6%
-18.1% -23.8% -1.0% -0.5% 6.7% 20.5% 10.2% -12.6% 19.2% -1.1% 22.9% 9.4%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?